The Peripheral Immune Traits Changed in Patients with Multiple System Atrophy

Overview

Journal Brain Sci

Publisher MDPI

Date 2023 Feb 25

PMID 36831748

Authors

Zhenxiang Gong

Rong Gao

Li Ba

Yang Liu

Hongyan Hou

Min Zhang

Affiliations

Soon will be listed here.

Abstract

A growing body of evidence suggests immune involvement in the pathology of multiple system atrophy (MSA). Research on detailed peripheral immune indices, however, is relatively sparse, and is one of the intriguing aspects of MSA yet to be elucidated. A total of 26 MSA patients and 56 age-and sex-matched healthy controls (HC) were enrolled in the current case-control study to delineate the peripheral immune traits of MSA patients. The ratio of CD4/CD8 T cells, natural killer cells, CD28 expression on both CD4 T cells and CD8 T cells increased in MSA patients compared to HC, but CD8 T cells and active marker (HLA-DR) expression on total T cells decreased ( < 0.05). This study sheds light on the dysregulation of cellular immunity in MSA, pointing to future mechanistic research.

Citing Articles

Detecting ferroptosis and immune infiltration profiles in multiple system atrophy using postmortem brain tissue.

Chen L, Mao L, Lu H, Liu P Front Neurosci. 2024; 17:1269996.

PMID: 38222105 PMC: 10784378. DOI: 10.3389/fnins.2023.1269996.

References

Madetko N, Migda B, Alster P, Turski P, Koziorowski D, Friedman A . Platelet-to-lymphocyte ratio and neutrophil-tolymphocyte ratio may reflect differences in PD and MSA-P neuroinflammation patterns. Neurol Neurochir Pol. 2022; 56(2):148-155. DOI: 10.5603/PJNNS.a2022.0014. View

Stevens C, Rowe D, Morel-Kopp M, Orr C, Russell T, Ranola M . Reduced T helper and B lymphocytes in Parkinson's disease. J Neuroimmunol. 2012; 252(1-2):95-9. DOI: 10.1016/j.jneuroim.2012.07.015. View

Engelhardt B, Vajkoczy P, Weller R . The movers and shapers in immune privilege of the CNS. Nat Immunol. 2017; 18(2):123-131. DOI: 10.1038/ni.3666. View

Jellinger K . Heterogeneity of Multiple System Atrophy: An Update. Biomedicines. 2022; 10(3). PMC: 8945102. DOI: 10.3390/biomedicines10030599. View

Csencsits-Smith K, Suescun J, Li K, Luo S, Bick D, Schiess M . Serum Lymphocyte-Associated Cytokine Concentrations Change More Rapidly over Time in Multiple System Atrophy Compared to Parkinson Disease. Neuroimmunomodulation. 2017; 23(5-6):301-308. PMC: 5491391. DOI: 10.1159/000460297. View

Ochoa J, Makarenkova V . T lymphocytes. Crit Care Med. 2005; 33(12 Suppl):S510-3. DOI: 10.1097/01.ccm.0000186788.71460.53. View

Rydbirk R, Folke J, Busato F, Roche E, Chauhan A, Lokkegaard A . Epigenetic modulation of AREL1 and increased HLA expression in brains of multiple system atrophy patients. Acta Neuropathol Commun. 2020; 8(1):29. PMC: 7063795. DOI: 10.1186/s40478-020-00908-7. View

Menees K, Lee J . New Insights and Implications of Natural Killer Cells in Parkinson's Disease. J Parkinsons Dis. 2022; 12(s1):S83-S92. PMC: 9535577. DOI: 10.3233/JPD-223212. View

Esensten J, Helou Y, Chopra G, Weiss A, Bluestone J . CD28 Costimulation: From Mechanism to Therapy. Immunity. 2016; 44(5):973-88. PMC: 4932896. DOI: 10.1016/j.immuni.2016.04.020. View

10.

George S, Tyson T, Rey N, Sheridan R, Peelaerts W, Becker K . T Cells Limit Accumulation of Aggregate Pathology Following Intrastriatal Injection of α-Synuclein Fibrils. J Parkinsons Dis. 2021; 11(2):585-603. PMC: 8150548. DOI: 10.3233/JPD-202351. View

11.

Jellinger K . Multiple System Atrophy: An Oligodendroglioneural Synucleinopathy1. J Alzheimers Dis. 2017; 62(3):1141-1179. PMC: 5870010. DOI: 10.3233/JAD-170397. View

12.

Tian J, Dai S, Jiang S, Yang W, Yan Y, Lin Z . Specific immune status in Parkinson's disease at different ages of onset. NPJ Parkinsons Dis. 2022; 8(1):5. PMC: 8748464. DOI: 10.1038/s41531-021-00271-x. View

13.

OBrien K, Finlay D . Immunometabolism and natural killer cell responses. Nat Rev Immunol. 2019; 19(5):282-290. DOI: 10.1038/s41577-019-0139-2. View

14.

Yamasaki R, Yamaguchi H, Matsushita T, Fujii T, Hiwatashi A, Kira J . Early strong intrathecal inflammation in cerebellar type multiple system atrophy by cerebrospinal fluid cytokine/chemokine profiles: a case control study. J Neuroinflammation. 2017; 14(1):89. PMC: 5404297. DOI: 10.1186/s12974-017-0863-0. View

15.

Gilman S, Wenning G, Low P, Brooks D, Mathias C, Trojanowski J . Second consensus statement on the diagnosis of multiple system atrophy. Neurology. 2008; 71(9):670-6. PMC: 2676993. DOI: 10.1212/01.wnl.0000324625.00404.15. View

16.

Schwab A, Thurston M, Machhi J, Olson K, Namminga K, Gendelman H . Immunotherapy for Parkinson's disease. Neurobiol Dis. 2020; 137:104760. PMC: 7933730. DOI: 10.1016/j.nbd.2020.104760. View

17.

Jiang S, Gao H, Luo Q, Wang P, Yang X . The correlation of lymphocyte subsets, natural killer cell, and Parkinson's disease: a meta-analysis. Neurol Sci. 2017; 38(8):1373-1380. DOI: 10.1007/s10072-017-2988-4. View

18.

Wang S, van de Pavert S . Innate Lymphoid Cells in the Central Nervous System. Front Immunol. 2022; 13:837250. PMC: 8852840. DOI: 10.3389/fimmu.2022.837250. View

19.

Matsuse D, Yamasaki R, Maimaitijiang G, Yamaguchi H, Masaki K, Isobe N . Early decrease in intermediate monocytes in peripheral blood is characteristic of multiple system atrophy-cerebellar type. J Neuroimmunol. 2020; 349:577395. DOI: 10.1016/j.jneuroim.2020.577395. View

20.

Nicoletti A, Fagone P, Donzuso G, Mangano K, Dibilio V, Caponnetto S . Parkinson's disease is associated with increased serum levels of macrophage migration inhibitory factor. Cytokine. 2011; 55(2):165-7. DOI: 10.1016/j.cyto.2011.03.027. View